BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• FDA

  Emblation Limited Announces CE Mark for Microwave Therapy System Aimed at Dermatology and Podiatry

  November 12, 2012

   · 

  2 min read
• Drug Development

  Savient Pharmaceuticals, Inc. Release: New Data Published in Annals of the Rheumatic Diseases Confirm Long-Term Safety and Efficacy of KRYSTEXXA® for the Treatment of Refractory Chronic Gout

  November 12, 2012

   · 

  9 min read
• Drug Development

  MorphoSys AG Reports Successful Phase 1 Study of MOR103 Using a Subcutaneous Administration

  November 12, 2012

   · 

  3 min read
• International Drug & Explosives Detection Company IDenta Corporation Updates Retail Drug Store Marketing

  November 12, 2012

   · 

  2 min read
• BioMidwest

  Beth Israel Deaconess Medical Center, Harvard Medical School Study Confirms Cannabis Science Inc.'s Approach to Development of CS-TATI-1 to Inhibit Kaposi Sarcoma

  November 12, 2012

   · 

  5 min read
• ICON-PLC Central Laboratories Doubles Biospecimen Storage Capacity

  November 12, 2012

   · 

  1 min read
• BioCapital

  Spherix Announces Closing of Private Placement of $2.6 Million in Common Stock and Warrants

  November 12, 2012

   · 

  1 min read
• Career Advice

  Post-Social Recruiting

  November 12, 2012

   · 

  5 min read
• MethylGene Announces $26.1 Million Private Placement

  November 12, 2012

   · 

  9 min read
• Drug Development

  Boehringer Ingelheim Corporation’s Liver Drug Shows Up to 85% Viral Cure in Phase 2

  November 12, 2012

   · 

  5 min read